S. E. Gibson et al.
anes, 6.0 mmol) was added to diamine (+)-13 (1.260 g, 3.00 mmol) in
THF(40 mL) at ꢀ788C. The solution was allowed to warm to room tem-
perature (30 min) and was recooled to ꢀ788C. Heat-gun-dried lithium
chloride (0.127 g, 3.00 mmol) in THF(10 mL) was added through a can-
nula and the reaction mixture was stirred for 5 min before a solution of
complex 19 (0.346 g, 1.00 mmol) in THF(6 mL) was introduced. The re-
action mixture was stirred for 1 h, then propargyl bromide (1.01 mL,
80% in toluene, 9.0 mmol) was added through a syringe. Stirring was
continued for a further 1 h at ꢀ788C before MeOH (2 mL) was added
and the solvent removed in vacuo. Purification of the resulting residue by
flash column chromatography (silica gel; hexane/diethyl ether 9:1!5:5)
afforded (+)-23 as a yellow oil (0.345 g, 92%). Rf =0.18 (silica gel;
hexane/diethyl ether 4:1). Enantiomeric excess was determined by HPLC
2.27m in hexanes, 3.0 mmol) was added to diamine (+)-13 (0.630 g,
1.50 mmol) in THF(20 mL) at ꢀ788C. The solution was allowed to warm
to room temperature (30 min) and was recooled to ꢀ788C. Heat-gun-
dried lithium chloride (0.064 g, 1.50 mmol) in THF(5 mL) was added
through a cannula and the reaction mixture was stirred for 5 min before
a solution of complex 19 (0.176 g, 0.50 mmol) in THF(3 mL) was intro-
duced. The reaction mixture was stirred for 1 h, then acetone (0.33 mL,
4.5 mmol) was added followed immediately by BF3·OEt2 complex
(0.38 mL, 3.0 mmol). Stirring was continued for a further 1 h at ꢀ788C
before MeOH (2 mL) was added and the solvent removed in vacuo. Puri-
fication of the resulting residue by flash column chromatography (silica
gel; hexane/diethyl ether 9:1!1:1) afforded (+)-25 as
a yellow oil
(0.177 g, 88%). Rf =0.20 (silica gel; hexane/diethyl ether 1:2). Enantio-
meric excess was determined by HPLC analysis (Chiralcel OD-H, n-
analysis (Chiralcel OD-H, n-hexane/propan-2-ol 95:5, 0.5 mLminꢀ1
330 nm); R enantiomer tr =20.2 min (major); S enantiomer tr =22.3 min
(minor): 75% ee. [a]D20 =+26 (c=0.034 in CHCl3); IR (CH2Cl2): n˜max
,
hexane/propan-2-ol 90:10, 0.5 mLminꢀ1
, 330 nm); R enantiomer tr =
=
14.5 min (major); S enantiomer tr =16.3 min (minor): 78% ee. [a]2D0 =+38
(c=0.010 in CHCl3); IR (CH2Cl2): n˜max =1966 (CꢁO), 1890 cmꢀ1 (CꢁO);
1H NMR (300 MHz, CDCl3): d=1.17 (s, 3H; C(CH3)(CH3)OH), 1.22 [s,
3H; C(CH3)(CH3)OH], 2.21 (s, 1H; OH), 3.46 (s, 6H; CH2OCH3 2),
3.69 (s, 3H; CHOCH3), 3.71 (s, 1H; CHC(CH3)2OH), 4.08–4.27 (m, 4H;
CH2OCH3 2), 5.42 (s, 1H; CCrH), 5.58 (s, 1H; CCrH), 5.70 ppm (s, 1H;
1967 (CꢁO), 1890 cmꢀ1 (CꢁO); 1H NMR (300 MHz, CDCl3): d=2.07
(virt t, J=2.5 Hz, 1H; CHCH2CꢁCH), 2.65–2.70 (m, 2H; CHCH2Cꢁ
CH), 3.470 (s, 3H; OCH3) 3.474 (s, 3H; OCH3) 3.60 (s, 3H; OCH3), 4.11
(virt t, J=5.7 Hz, 1H; CHCH2CꢁCH), 4.17–4.28 (m, 4H; CH2OCH3 2),
5.35 (s, 1H; CCrH), 5.42 (s, 1H; CCrH), 5.58 ppm (s, 1H; CCrH); 13C NMR
(75 MHz, CDCl3): d=27.3 (CHCH2CꢁCH), 58.6 (CHOCH3), 59.0
(CH2OCH3 2), 71.6 (CHCH2CꢁCH), 72.7, 72.9 (CH2OCH3), 79.0
(CHCH2CꢁCH), 79.5 (CHCH2CꢁCH), 89.2, 89.3, 91.3 (CCrH), 106.6,
106.8 (CCrCH2), 111.1 (CCrCH), 232.5 ppm (CꢁO3); MS (EI): m/z (%):
384 (24) [M+], 353 (4) [M+ꢀOCH3], 345 (18) [M+ꢀCH2CꢁCH], 300
(100) [M+ꢀ3CO], 269 (12) [M+ꢀ3COꢀOCH3], 261 (14) [M+
ꢀ3COꢀCH2CꢁCH], 240 (30) [M+ꢀ3COꢀ2OCH3+2H], 209 (67) [M+
ꢀ3COꢀ3OCH3+2H]; elemental analysis calcd (%) for C18H20CrO6
(384.34): C 56.25, H 5.24; found: C 56.34, H 5.25.
C
CrH); 13C NMR (90 MHz, CDCl3): d=25.4, 25.7 [C(CH3)2OH], 58.9
(CH2OCH3 2), 60.7 (CHOCH3), 73.7 (CH2 2), 74.6 (COH), 87.7
(CHCOH), 91.9, 93.1, 94.3 (CCrH), 104.1, 104.9, 106.4 (CCrC), 239.4 ppm
(CꢁO3); MS (EI): m/z (%): 404 (72) [M+], 373 (13) [M+ꢀOCH3], 356
(3) [M+ꢀOCH3ꢀOH], 345 (5) [M+ꢀ(CH3)2COH], 320 (34) [M+ꢀ3CO],
289 (4) [M+ꢀ3COꢀOCH3], 258 (6) [M+ꢀ3COꢀ2OCH3], 228 (15) [M+
ꢀ3COꢀ2CH2OCH3ꢀ2H], 210 (27) [M+ꢀCr(CO)3ꢀ(CH3)2COH+H],
200 (12) [M+ꢀ3COꢀOCH3ꢀ(CH3)2COHꢀ2CH3], 178 (100) [M+
ꢀCr(CO)3ꢀ(CH3)2COHꢀOCH3]; elemental analysis calcd (%) for
C18H24CrO7 (404.09): C 53.46, H 5.98; found: C 53.40, H 6.06.
(+)-(R)-Tricarbonyl[1-(2-hydroxy-1-methoxy-2,2-diphenylethyl)-3,5-bis-
(methoxymethyl)benzene]chromium(0)
((+)-24):
n-Butyllithium
(+)-(R,R,R)-Tricarbonyl[1,3,5-tris(1-methoxy-3-hydroxy-propyl)ben-
zene]chromium(0) (+)-26: n-Butyllithium (2.40 mL, 2.50m in hexanes,
6.0 mmol) was added dropwise to a stirred solution of diamine (+)-13
(1.260 g, 3.00 mmol) in dry THF(24 mL) at ꢀ788C. The solution was al-
lowed to warm to room temperature over a period of 30 min and then re-
cooled to ꢀ788C before a solution of heat-gun-dried lithium chloride
(0.127 g, 3.00 mmol) in THF(8 mL) was added through a cannula. The
reaction mixture was stirred for a further 5 min, then a precooled solu-
tion (ꢀ788C) of complex 19 (0.346 g, 1.00 mmol) in THF(8 mL) was in-
troduced dropwise through a short cannula. Stirring was continued for a
period of 60 min before a cooled solution (ꢀ788C) of ethylene oxide
(2.5 mL, 50.0 mmol) in THF(2.5 mL) was added through a short cannula.
Immediately after the addition of epoxide, BF3·OEt2 complex (0.76 mL,
6.0 mmol) was added in one portion leading to a colour change of solu-
tion from red to yellow. The reaction mixture was then stirred for 1.5 h at
ꢀ788C, MeOH (2 mL) was then added and the solvent was removed in
vacuo. Purification of the residue by flash column chromatography (silica
gel; ethyl acetate/methanol 99:1!95:5) afforded (+)-26 as a yellow oil
which solidified upon standing (0.330 g, 69%). Rf =0.50 (silica gel; ethyl
acetate/methanol 9:1). Enantiomeric excess was determined by HPLC
(0.72 mL, 2.50m in hexanes, 1.8 mmol) was added dropwise to a stirred
solution of diamine (+)-13 (0.378 g, 0.90 mmol) in THF(10 mL) at
ꢀ788C. The solution was allowed to warm to room temperature over a
period of 30 min and was recooled to ꢀ788C. A solution of heat-gun-
dried lithium chloride (0.038 g, 0.90 mmol) in THF(5 mL) was added
through a cannula and the reaction mixture was stirred for a further
5 min before a precooled solution (ꢀ788C) of complex 19 (0.104 g,
0.30 mmol) in THF(5 mL) was introduced dropwise through a short can-
nula. Stirring was continued for 60 min, then benzophenone (0.492 g,
2.70 mmol) in THF(2 mL) was added in one portion through a cannula
followed immediately by BF3·OEt2 complex (0.23 mL, 1.8 mmol). The re-
action mixture was stirred for a further 1 h at ꢀ788C before MeOH
(1 mL) was added and the solvent removed in vacuo. Purification of the
resulting residue by flash column chromatography (silica gel; hexane/di-
ethyl ether 9:1!7:3) afforded (+)-24 as a yellow oil, which solidified
upon standing (0.154 g, 97%). Rf =0.45 (silica gel; hexane/diethyl ether
1:1). Enantiomeric excess was determined by HPLC analysis (Chiralcel
OD-H, n-hexane/propan-2-ol 90:10, 0.5 mLminꢀ1, 330 nm); R enantiomer
tr =14.8 min (major); S enantiomer tr =31.4 min (minor): 76% ee. [a]20
=
+9 (c=0.009 in CHCl3); m.p. 99–1018C; IR (CH2Cl2): n˜max =1964 (CꢁDO),
1888 cmꢀ1 (CꢁO); 1H NMR (500 MHz, CDCl3): d=3.04 (s, 1H; OH),
3.20 (s, 3H; OCH3), 3.43 (s, 3H; OCH3), 3.66 (s, 3H; OCH3), 3.69 (d, J=
12.2 Hz, 1H; CHH(OCH3)), 3.90 (d, J=12.2 Hz, 1H; CHH(OCH3)), 4.12
(d, J=12.1 Hz, 1H; CHH(OCH3)), 4.21 (d, J=12.1 Hz, 1H; CHH-
(OCH3)), 4.45 (s, 1H; CHC(OH)Ph2), 4.80 (s, 1H; CCrH), 5.49 (s, 1H;
CCrH), 5.70 (s, 1H; CCrH), 7.20–7.55 ppm (m, 10H; CArH); 13C NMR
(90 MHz, CDCl3): d=58.5, 58.6, 59.6 (OCH3), 72.1, 72.7 (CH2), 81.4
(CPh2(OH)), 84.7 (CHCPh2(OH)), 93.0, 93.2, 94.0 (CCrH), 104.8, 104.6,
104.7 (CCrC), 127.0, 127.2, 127.4, 128.0, 128.2 (CArH), 142.6, 144.8 (CArC),
232.8 ppm (CꢁO3); MS (EI): m/z (%): 528 (47) [M+], 497 (9) [M+
ꢀOCH3], 444 (49) [M+ꢀ3CO], 344 (11) [M+ꢀCr(CO)3ꢀOCH3ꢀOH],
281 (6) [M+ꢀCr(CO)3ꢀ3OCH3ꢀH2O], 209 (100) [M+ꢀCr(CO)3ꢀPh2-
COH], 178 (99) [M+ꢀCr(CO)3ꢀPh2COHꢀOCH3]; elemental analysis
calcd (%) for C24H30CrO6 (528.12): C 63.63, H 5.35; found: C 63.59, H
5.38.
analysis (Chiralpak AD, n-hexane/propan-2-ol 80:20, 0.5 mLminꢀ1
,
330 nm); S,S,S enantiomer tr =20.6 min (minor); R,R,R enantiomer tr =
23.0 min (major): 93% ee. [a]2D0 =+96 (c=0.018 in CHCl3); m.p. 112–
1148C; IR (CH2Cl2): n˜max =3250 (OH) 1963 (CꢁO), 1887 cmꢀ1 (CꢁO);
1H NMR (500 MHz, CDCl3): d=1.90–1.93 (m, 3H; CHHCH2OH3),
1.96–1.99 (m, 3H; CHHCH2OH3), 2.36 (s, 3H; OH3), 3.60 (s, 9H;
OCH3 3), 3.79 (s, 6H, CHHCH2OH3), 4.25–4.29 (m, 3H;
CHCH2CH2OH3), 5.55 ppm (s, 3H; CCrH3); 13C NMR (125 MHz,
CDCl3): d=41.3 (CH2CH2OH3), 58.9 (OCH3 3), 59.7 (CH2OH3),
79.9 (CHOCH3 3), 89.7 (CCrH3), 109.2 (CCrCH3), 232.8 ppm (CꢁO
3); MS (EI): m/z (%): 478 (2) [M+], 402 (6) [M+ꢀCH2CH2OHꢀOCH3],
332 (13) [M+ꢀ2COꢀ2CH2CH2OH], 310 (7) [M+ꢀCH3OCH2CH2-
CH2OHꢀCH3CH2OHꢀCH3OH], 297 (100) [M+ꢀ2CH3OCH2CH2-
CH2OHꢀH], 270 (27) [M+ꢀCOꢀ2CH3OCH2CH2CH2OH], 265 (38) [M+
ꢀ2CH3OCH2CH2CH2OHꢀCH3OHꢀH]; HRMS (EI): m/z calcd for
C21H30CrO9: 478.1295; found: 478.1276.
(+)-(R)-Tricarbonyl[1-(2-hydroxy-1-methoxy-2-methylpropyl)-3,5-bis-
(methoxymethyl)benzene]chromium(0) (+)-25: n-Butyllithium (1.32 mL,
(+)-(R,R,R)-Tricarbonyl[1,3,5-tris(1-diphenylphosphino-1-methoxymeth-
yl)benzene]chromium(0) ((+)-28): n-Butyllithium (1.49 mL, 2.50m in
146
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2006, 12, 138 – 148